ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Policy To Practice: PBM Reform, TrumpRx, And Global Drug Development

  Policy shifts are reshaping PBM oversight, driving transparent drug‑pricing tools, and influencing global responses that affect affordability, access, and future pharma development.

• Bespoke RTSM Systems Empower Precision Medicine

  Randomization & trial supply management (RTSM) are critical functions of clinical trial IRT systems, supporting patient randomization plus managing drug inventory, site resupply, and participant dispensation.

• Broadening Eligibility Criteria Among Cancer Clinical Trials Patients

  This study challenges the commonly applied exclusionary approach to clinical trials, particularly cancer trials, that underrepresent certain populations and limit the generalizability of research advancements.

• Clinical Trial Budgeting Faces Pressure To Modernize

  Outdated budget data slows trial startup. Real-time market benchmarking helps sites and sponsors negotiate faster and get treatments to patients sooner.

• Accelerated Approval As The New "Norm" In Gene Therapy For Rare Diseases

  Gene therapy has revolutionized treatment prospects for rare genetic disorders by enabling corrective or replacement strategies at the molecular level.

• Building Patient-Focused eCOA Strategies: Insights And Best Practices

  Discover why the use of electronic clinical outcome assessments (eCOA) in clinical research is becoming an increasingly important part of study design in this article.

• Technology Fragmentation Is One Of The Biggest Hidden Risks In Clinical Trials

  Reclaim your research day by reducing manual data entry. Learn how connecting operational and financial workflows eases administrative burdens and supports site sustainability.

• Considerations For Implementing The Best eCOAs In Your Trial Design

  Dive into considerations when deciding on the best COAs to implement as well as best practices when developing your eCOA strategy in this blog.

• Reinventing Prostate Cancer Diagnostics With An All-In-One Platform

  Discover how a lean research team saved an estimated $100k and reached 95% data compliance by unifying their clinical workflow.

• The Hidden Cost Of Preferred Vendors

  Familiar vendors offer comfort — but at the cost of innovation, fit, and fresh thinking. Ease shouldn’t outweigh excellence when selecting partners for your clinical trial.